<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04226118</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL19_0036</org_study_id>
    <nct_id>NCT04226118</nct_id>
  </id_info>
  <brief_title>Efficacy of an Infrared Visualization Technique for the Identification of the Peripheral Venous Access Site in Patients With Cystic Fibrosis Aged 12 Years and Older</brief_title>
  <acronym>MUCOVEINE</acronym>
  <official_title>Efficacy of an Infrared Visualization Technique for the Identification of the Peripheral Venous Access Site in Patients With Cystic Fibrosis Aged 12 Years and Older</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cystic fibrosis is a rare chronic genetic disease that mainly affects the respiratory tract
      and the digestive system. Their management includes multi-year intravenous antibiotic
      treatments and repeated venous sampling. The venous access is a source of difficulties that
      nurses who take care of these patients face on a daily basis. In addition, multiple attempts
      at punctures can induce anxiety and pain in patients. It is therefore important to limit
      failures.

      Vein visualization technologies exist: guidance echo, portable trans lumination or infrared
      visualization can guide venipuncture and limit failures.

      Compared with the guided echo or the portable trans lumination, the infrared visualization is
      easy to use and does not pose a risk for the patient. Nevertheless, studies evaluating this
      technique are few in chronic diseases and mainly conducted in young children.

      This study aims to show that the use of a vein illumination system (VIS) should improve the
      peripheral venous access at the first attempt (thus limiting venous lesions) in adolescent
      and adult patients with cystic fibrosis, and improve comfort of the patient (pain,
      apprehension of the gesture).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background :

      Cystic fibrosis is a rare chronic genetic disease that mainly affects the respiratory tract
      and the digestive system. Their management includes multi-year intravenous antibiotic
      treatments and repeated venous sampling. The venous access is a source of difficulties that
      nurses who take care of these patients face on a daily basis. In addition, multiple attempts
      at punctures can induce anxiety and pain in patients. It is therefore important to limit
      failures.

      Vein visualization technologies exist: guidance echo, portable trans lumination or infrared
      visualization can guide venipuncture and limit failures.

      Compared with the guided echo or the portable trans lumination, the infrared visualization is
      easy to use and does not pose a risk for the patient. Nevertheless, studies evaluating this
      technique are few in chronic diseases and mainly conducted in young children.

      This study aims to show that the use of a vein illumination system (VIS) should improve the
      peripheral venous access at the first attempt (thus limiting venous lesions) in adolescent
      and adult patients with cystic fibrosis, and improve comfort of the patient (pain,
      apprehension of the gesture).

      Objectives of the study :

      The main objective of the study is to demonstrate that the use of a vein illumination system
      (VIS) for the placement of a peripheral venous line or venous sampling on the hand, forearm
      or fold of the elbow improves peripheral venous access (PVA) successful on the first attempt.

      The secondary objectives are :

        -  To study the efficacy of VIS for peripheral venous access (placement of a peripheral
           venous line or peripheral venous sampling in the hand, forearm or elbow) on the number
           of attempts.

        -  To study the impact of the use of SIV on the patient's pain felt during the peripheral
           venous access procedure.

        -  To study the impact of VIS on patient anxiety prior to peripheral venous access.

        -  To describe the nurses and nursing students satisfaction with the use of the VIS device
           for peripheral venous access.

        -  To study the determinants of the success of peripheral venous access at the first
           attempt among the characteristics of nurses and nursing students (age, year of obtaining
           their diploma, experience within the cystic fibrosis ressource and competence center).

        -  To describe the nurses and nursing students satisfaction with the use of A-DIVA scale.

      Study design The study will last 36 months. It is an open and randomized multicenter cluster
      study, with sequential allocation of the device (stepped wedge allocation), comparing a group
      of patients benefiting from a technique of locating the puncture site by a venous
      illumination system for a peripheral venoux access (hand, forearm, fold of the elbow) to a
      group of patients whose veins are identified according to the usual modality of a peripheral
      venoux access. The cluster is defined by the Cystic Fibrosis Resource and Competence Center
      (CRCM).

      Expected results

      For the patients, the use of a venous illumination system device during the peripheral venous
      access should facilitate the success of the gesture on the first attempt, allowing to :

        -  Reduce their pain due to multiple attempts.

        -  Reduce their anxiety associated with peripheral venous access.

        -  Preserve their venous capital This could have an impact on their care, such as making it
           easier to consult for them and being less anxious about peripheral venous access.

      For the nurses, using a venous illimunation system device could

        -  Reduce their apprehension of peripheral venous access gesture

        -  Save their time with fewer peripheral venous access are repeated. It is considered that
           this technique will be distributed to all Cytic Fibrosis Ressource and Competence
           Centers (CRCM) in order to improving the comfort of the chronically ill patient with
           repeated blood tests and intravenous treatments.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2020</start_date>
  <completion_date type="Anticipated">April 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients for whom peripheral venous access was performed from the first attempt.</measure>
    <time_frame>at time of peripheral venous access</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of attempts to place a peripheral venous line or perform peripheral venous</measure>
    <time_frame>at time of peripheral venous access</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average pain score on Visual Analogue Scale (VAS) after successful peripheral venous access act.</measure>
    <time_frame>at most 10 min after the venous act</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average anxiety score on State-Trait Anxiety Inventory (STAI-Y)</measure>
    <time_frame>at most 10 min before the venous act</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of nurses and nursing student satisfied by the use of a vein illumination system</measure>
    <time_frame>at the end of the study ( at 14 months)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">294</enrollment>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients who have a peripheral venous access by a classic procedure, without using a Vein Illumination System.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who have a peripheral venous access by a procedure using a Vein Illumination System.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vein Illumintion System device</intervention_name>
    <description>Spotting veins of a patient by use of a Vein Illumintion System device</description>
    <arm_group_label>Experimental Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with cystic fibrosis aged 12 years and over

          -  Cystic Fibrosis diagnosis has been confirmed by a positive sweat test and/or 1 to 2
             genetic mutations

          -  Patients requiring peripheral venous access (hand, forearm, or more of the elbow) for
             intravenous infusion with epicranial or short catheter, or for a blood sample

          -  Patients who have a score of 4 or higher on the A-DIVA scale (self-administered
             questionnaire completed by the IDE assessing the difficulty of peripheral venous
             access on a Likert scale from 0 to 8)

          -  Patients informed in writing of the terms of the study and provided written informed
             consent to participate (consent of the person in charge of parental authority if the
             patient is a minor).

          -  Patients affiliated to a social security system

        Exclusion Criteria:

          -  Patient who has already participated in the study

          -  Patients who have a central venous approach

          -  Patients who have a venous approach of the midline type

          -  Patients taken care of for vital emergency

          -  Patient deprived of liberty or placed under tutorship or curatorship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nad√®ge GORIOT RAYNAUD</last_name>
    <phone>4.94.38.17.52</phone>
    <phone_ext>+33</phone_ext>
    <email>nadege.goriot-raynaud@chu-lyon.fr</email>
  </overall_contact>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 9, 2020</study_first_submitted>
  <study_first_submitted_qc>January 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2020</study_first_posted>
  <last_update_submitted>January 10, 2020</last_update_submitted>
  <last_update_submitted_qc>January 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

